RGH-706 / Gedeon Richter - LARVOL DELTA

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome (clinicaltrials.gov) - P2 | N=39 | Completed | Sponsor: Gedeon Richter Plc. | Active, not recruiting ➔ Completed | N=176 ➔ 39

Enrollment change • Trial completion • Prader–Willi syndrome